http://www.mdpi.com/journal/marinedrugs/special_issues/marine-drugs-china/ Submission All papers should be submitted to marinedrugs@mdpi.com with copy to the Editors. To be published continuously until the deadline and papers will be listed together at the special websites. Both, research articles and review articles are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editors for announcment on this website. Submitted papers should not have been published previously, nor be under consideration for publication elsewhere. All papers are refereed through a peer-review process. A guide for authors, sample copies and other relevant information for submitting papers are available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed quarterly journal published by MDPI. Please visit the Instructions for Authors page before submitting a paper. Open Access publication fees are 1000 CHF per paper. English correction fees (250 CHF) will be added in certain cases (1250 CHF per paper for those papers that require extensive additional formatting and/or English corrections). http://www.mdpi.com/1660-3397/7/2/113/ Marine animals and plants such as sponges, sea squirts, corals, worms and algae host diverse and abundant symbiotic microorganisms. Marine microbial symbionts are possible the true producers or take part in the biosynthesis of some bioactive marine natural products isolated from the marine organism hosts. Investigation of the pharmaceutical metabolites may reveal the biosynthesis mechanisms of related natural products and solve the current problem of supply limitation in marine drug development. This paper reviews the advances in diversity revelation, biological activity and related pharmaceutical metabolites, and functional genes of marine microbial symbionts from the China Sea. http://www.mdpi.com/1660-3397/7/2/113/ Mon, 20 Apr 2009 00:00:00 CEST Marine Drugs 2009-04-20 7 2 Review 113 129 1660-3397 Advances in Marine Microbial Symbionts in the China Sea and Related Pharmaceutical Metabolites 2009-04-20 doi: 10.3390/md7020113 Zhiyong Li